Schroder Investment Management Group Buys 41,414 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Schroder Investment Management Group raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPHFree Report) by 12.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 384,936 shares of the company’s stock after acquiring an additional 41,414 shares during the quarter. Schroder Investment Management Group’s holdings in U.S. Physical Therapy were worth $35,310,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Great Lakes Advisors LLC boosted its stake in U.S. Physical Therapy by 0.3% in the second quarter. Great Lakes Advisors LLC now owns 37,219 shares of the company’s stock valued at $4,518,000 after acquiring an additional 99 shares during the last quarter. Huntington National Bank boosted its stake in U.S. Physical Therapy by 71.8% in the second quarter. Huntington National Bank now owns 280 shares of the company’s stock valued at $34,000 after acquiring an additional 117 shares during the last quarter. MetLife Investment Management LLC boosted its stake in U.S. Physical Therapy by 1.8% in the second quarter. MetLife Investment Management LLC now owns 6,900 shares of the company’s stock valued at $838,000 after acquiring an additional 123 shares during the last quarter. Advisor Group Holdings Inc. raised its holdings in U.S. Physical Therapy by 1.3% in the fourth quarter. Advisor Group Holdings Inc. now owns 12,435 shares of the company’s stock worth $1,008,000 after purchasing an additional 163 shares during the period. Finally, Legal & General Group Plc raised its holdings in U.S. Physical Therapy by 0.5% in the second quarter. Legal & General Group Plc now owns 31,940 shares of the company’s stock worth $3,488,000 after purchasing an additional 164 shares during the period.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $105.40 on Friday. The firm has a 50-day moving average of $96.93 and a 200-day moving average of $93.05. U.S. Physical Therapy, Inc. has a one year low of $78.08 and a one year high of $124.11. The company has a market cap of $1.59 billion, a PE ratio of 78.07, a price-to-earnings-growth ratio of 5.01 and a beta of 1.38. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.02. The company had revenue of $154.80 million during the quarter, compared to the consensus estimate of $150.24 million. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The company’s quarterly revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.58 EPS. As a group, equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.75 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 5th. Investors of record on Tuesday, March 12th will be issued a dividend of $0.44 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Monday, March 11th. This represents a $1.76 annualized dividend and a dividend yield of 1.67%. U.S. Physical Therapy’s payout ratio is presently 127.41%.

Analyst Upgrades and Downgrades

USPH has been the topic of a number of research analyst reports. JPMorgan Chase & Co. dropped their price objective on shares of U.S. Physical Therapy from $108.00 to $99.00 and set an “overweight” rating on the stock in a report on Friday, November 17th. Barrington Research lifted their price target on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. Finally, StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Thursday. One analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $119.67.

Get Our Latest Research Report on USPH

Insider Buying and Selling

In related news, Director Clayton Trier sold 1,170 shares of U.S. Physical Therapy stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $92.26, for a total transaction of $107,944.20. Following the completion of the sale, the director now owns 7,400 shares of the company’s stock, valued at approximately $682,724. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other U.S. Physical Therapy news, Director Clayton Trier sold 1,170 shares of the business’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $92.26, for a total value of $107,944.20. Following the completion of the sale, the director now owns 7,400 shares of the company’s stock, valued at approximately $682,724. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Graham D. Reeve sold 2,629 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.39, for a total transaction of $274,441.31. Following the completion of the sale, the chief operating officer now directly owns 6,902 shares of the company’s stock, valued at approximately $720,499.78. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,799 shares of company stock valued at $800,476. Company insiders own 1.80% of the company’s stock.

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHFree Report).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.